Correlation Between Virax Biolabs and Avalo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Avalo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Avalo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Avalo Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Avalo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Avalo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Avalo Therapeutics.
Diversification Opportunities for Virax Biolabs and Avalo Therapeutics
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Virax and Avalo is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Avalo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avalo Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Avalo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avalo Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Avalo Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Avalo Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.78 times more return on investment than Avalo Therapeutics. However, Virax Biolabs is 1.78 times more volatile than Avalo Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Avalo Therapeutics is currently generating about 0.05 per unit of risk. If you would invest 194.00 in Virax Biolabs Group on August 29, 2024 and sell it today you would earn a total of 8.00 from holding Virax Biolabs Group or generate 4.12% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Virax Biolabs Group vs. Avalo Therapeutics
Performance |
Timeline |
Virax Biolabs Group |
Avalo Therapeutics |
Virax Biolabs and Avalo Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Virax Biolabs and Avalo Therapeutics
The main advantage of trading using opposite Virax Biolabs and Avalo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Avalo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avalo Therapeutics will offset losses from the drop in Avalo Therapeutics' long position.Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
Avalo Therapeutics vs. AnaptysBio | Avalo Therapeutics vs. Arcellx | Avalo Therapeutics vs. Structure Therapeutics American | Avalo Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |